Healthcare Services

Global Gene Delivery Technologies Market Expected to Reach $8.46 Billion by 2030 with 14.5% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Gene Delivery Technologies Market Projected To Become By 2030 Based On Its 2026 Valuation?

The gene delivery technologies market has seen rapid expansion in recent years. It is expected to grow from $4.29 billion in 2025 to $4.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.7%. This historical growth can be attributed to factors such as an increase in gene therapy research, advancements in viral vector development, sustained academic research funding, the implementation of electroporation techniques, and various vaccine development programs.

The gene delivery technologies market size is anticipated to experience substantial growth in the upcoming years. Its value is projected to reach $8.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.5%. This expansion during the forecast period can be attributed to the broadening of gene therapy pipelines, innovations in delivery vectors, a rising demand for safer delivery methods, an increase in cell therapy applications, and heightened clinical trial activity. Prominent trends expected over the forecast horizon include the growing utilization of viral and non-viral delivery systems, increased integration into gene and cell therapy, the development of lipid nanoparticle technologies, a stronger focus on targeted gene delivery, and advancements in physical gene transfer methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp

Which Market Drivers Are Supporting The Expansion Of The Gene Delivery Technologies Market?

The anticipated rise in the number of cell and gene therapies is projected to fuel the expansion of the gene delivery technologies market moving forward. Cell and gene therapies are defined as medical interventions aimed at addressing or alleviating diseases through modifications to a patient’s genetic and cellular composition. The escalating volume of these therapies is primarily propelled by advancements in gene editing technologies, which are instrumental in their creation and commercialization. For example, in March 2025, IQVIA, a US-based provider of advanced analytics, technology solutions, and contract research services, reported that the volume of new CAR T trial starts reached 199 in 2024, and gene therapy trial starts reached 130; these figures represented increases of 54% and 65%, respectively. Consequently, the growing number of cell and gene therapies is a significant driver for the gene delivery technologies market.

What Segment Groups Are Identified Within The Gene Delivery Technologies Market?

The gene delivery technologies market covered in this report is segmented –

1) By Mode: Biological, Chemical, Physical

2) By Method: Ex Vivo, In Vivo, In Vitro

3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research

Subsegments:

1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles

2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents

3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation

Which Trends Are Shaping The Future Of The Gene Delivery Technologies Market?

Major companies engaged in gene delivery technologies are prioritizing the development of advanced products, such as the ProteoAnalyzer, to enhance their market position. The ProteoAnalyzer is an advanced automated system crafted by Agilent Technologies for protein analysis, specifically utilizing parallel capillary electrophoresis (CE) technology. As an illustration, in July 2024, Agilent Technologies Inc., a US-based life sciences organization, unveiled its ProteoAnalyzer system. This innovative platform is engineered for automated parallel capillary electrophoresis (CE), facilitating rapid, high-resolution protein analysis with minimal sample usage. This capability proves particularly valuable for researchers managing complex protein mixtures in the pharmaceutical, biopharma, and bioengineered food ingredient sectors, promoting quicker discoveries and advancements in translational research. The system’s ability for thorough examination of protein mixtures is critical for the creation of therapeutic proteins.

Which Companies Hold Significant Positions In The Gene Delivery Technologies Market?

Major companies operating in the gene delivery technologies market are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

Read the full gene delivery technologies market report here:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

How Is The Gene Delivery Technologies Market Distributed Across Key Geographic Regions?

North America was the largest region in the gene delivery technologies market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Delivery Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp

Browse Through More Reports Similar to the Global Gene Delivery Technologies Market 2026, By The Business Research Company

Testosterone Replacement Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/testosterone-replacement-therapy-global-market-report

Male Hypogonadism Global Market Report

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Non Surgical Cosmetic Procedures Global Market Report

https://www.thebusinessresearchcompany.com/report/non-surgical-cosmetic-procedures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795